Volume 41, Issue 5

Search all Medical Oncology articles

May 2024

Filter by

Volume:

Sort by

Date published:

New to old Old to new

37 articles in this issue

Challenges and strategies in relation to effective CAR-T cell immunotherapy for solid tumors
Guangxun Yuan
Mengke Ye
Xun Zeng
Review Article 23 April 2024 Article: 126
Part of 1 collection:

CAR T-cell therapy in cancer
Anti-cancer potential of zerumbone in cancer and glioma: current trends and future perspectives
Alborz Soroush
Siavash Pourhossein
Sepideh Karkon Shayan
Review Article 23 April 2024 Article: 125
Ferroptosis is an effective strategy for cancer therapy
Afrasyab Khan
Yu Huo
Yongzhong Hou
Review Article 23 April 2024 Article: 124
N-methyl-D-aspartate receptors and thymoquinone induce apoptosis and alteration in mitochondria in colorectal cancer cells
Ferhat Sirinyildiz
Simge Unay
Original Paper 23 April 2024 Article: 123
Part of 1 collection:

Mechanisms of resistance to cancer therapy
Comprehensive review of the repositioning of non-oncologic drugs for cancer immunotherapy
Abdur Rauf
Payal B. Joshi
Rekha Thiruvengadam
Review Article 23 April 2024 Article: 122
Part of 1 collection:

Regulatory T cells in cancer immunosuppression
Correction to: Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression
Afrah Fatthi Salama
Ali H. El-Far
Alaa Elmetwalli
Correction Open access 22 April 2024 Article: 121
FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner
Zhe Yin
Xiong Guo
Ziwei Wang
Original Paper 20 April 2024 Article: 120
The role of SWI/SNF complexes in digestive system neoplasms
Hanyun Liang
Xin Zheng
Jie Zheng
Review Article 17 April 2024 Article: 119
Identification of small molecule inhibitors against Lin28/let-7 to suppress tumor progression and its alleviation role in LIN28-dependent glucose metabolism
Rachanaa Raja
Rajamanikandan Sundararaj
Ruckmani Kandasamy
Original Paper 17 April 2024 Article: 118
Chlordiazepoxide against signalling, receptor and regulatory proteins of breast cancer: a structure-based in-silico approach
Ahad Amer Alsaiari
Amal F. Gharib
Mohammed Ageeli Hakami
Original Paper 17 April 2024 Article: 117
Liver cancer wars: plant-derived polyphenols strike back
Chengu Niu
Jing Zhang
Patrick I. Okolo 3rd
Review Article 16 April 2024 Article: 116
Exploring the immunomodulatory potential of Brahmi (Bacopa monnieri) in the treatment of invasive ductal carcinoma
Sohini Roy
Geetha Shanmugam
Koustav Sarkar
Original Paper 15 April 2024 Article: 115
Dual function of activated PPARγ by ligands on tumor growth and immunotherapy
Mingjun Chen
Huijie Wang
Yongzhong Hou
Review Article 15 April 2024 Article: 114
A novel α,β-unsaturated ketone inhibits leukemia cell growth as PARP1 inhibitor
Weijia Zhao
Min Mo
Baofei Sun
Original Paper 11 April 2024 Article: 113
Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
Khubaib Ali
Muhammad Nabeel
Hamid Saeed
Review Article 09 April 2024 Article: 112
Part of 2 collections:

Mechanisms of resistance to cancer therapy

Mechanisms of resistance to cancer therapy
Coadministration of doxorubicin with vitamin D3, Lactobacillus acidophilus, and Lactobacillus casei in the 4T1 mouse model of breast cancer: anticancer and enteroprotective effects
Mohammad Ali Mirzadeh
Majid Eslami
Abbas Pakdel
Original Paper 09 April 2024 Article: 111
Part of 1 collection:

Evolutionary Biology and Ecology of Cancer
Combination of IFN-gamma with STING agonist and PD-1 immune checkpoint blockade: a potential immunotherapy for gastric cancer
Shahnaz Hosseinzadeh
Mahsa Imani
Elham Safarzadeh
Original Paper 09 April 2024 Article: 110
Study of the effect of sFRP1 protein on molecules involved in the regulation of DNA methylation in CML cell line
Nazli Demirkiran
Bengusu Aydin
H. Ogun Sercan
Original Paper 09 April 2024 Article: 109
Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: new insights
Ahmadreza Lagzian
Marziye Askari
Yalda Malekzadegan
Review Aritcle 09 April 2024 Article: 108
Part of 1 collection:

Mechanisms of resistance to cancer therapy
Immunomodulatory effects of Diospyros peregrina fruit preparation (DFP) in non-small cell lung cancer (NSCLC) by utilizing dendritic cell-mediated antigen presentation and T helper (TH) cell differentiation
Nawaneetan Sriraman
Ankita Sarkar
Koustav Sarkar
Original Paper 05 April 2024 Article: 107
Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment
Alaa Elmetwalli
Mohamed O. Abdel-Monem
Mervat G. Hassan
Original Paper Open access 04 April 2024 Article: 106
Citalopram, an antipsychotic agent, induces G1/G0 phase cell cycle arrest and promotes apoptosis in human laryngeal carcinoma HEP-2 cells
Mohammed Salama
Abeer Ali
Seham Elabd
Original Paper Open access 04 April 2024 Article: 105
Unlocking the potential: phenylboronic acid as a nuclear-targeting boron agent for neutron capture therapy
Jiejian Chen
Yonghao Li
Guolong Liu
Original Paper 04 April 2024 Article: 104
Regulation of hippo signaling mediated apoptosis by Rauvolfia tetraphylla in triple-negative breast cancer
B. Balavaishnavi
M. Kamaraj
Mohammed Rafi Shaik
Original Paper 29 March 2024 Article: 103
Part of 1 collection:

Mechanisms of resistance to cancer therapy
Investigating the correlation between prominent viruses and hematological malignancies: a literature review
Arian Haghtalab
Milad Hejazi
Ataollah GhalibafSabbaghi
Review Article 28 March 2024 Article: 102
Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer
Abdulkarim S. Binshaya
Omar Saad Alkahtani
Hassan H. Almasoudi
Original Paper 28 March 2024 Article: 101
YWHAG promotes colorectal cancer progression by regulating the CTTN-Wnt/β-catenin signaling axis
Yuanben Wang
Yulin Cao
Zhaohui Huang
Original Paper 27 March 2024 Article: 100
Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer
Anne-Dorthe Mosgaard Knudsen
Mikala Wej Modvig
Annette Raskov Kodahl
Original Paper Open access 27 March 2024 Article: 99
Potential role of immune cell therapy in gynecological cancer and future promises: a comprehensive review
Sandipan Dasgupta
Sakuntala Gayen
Souvik Roy
Review Article 27 March 2024 Article: 98
Part of 2 collections:

Regulatory T cells in cancer immunosuppression

Regulatory T cells in cancer immunosuppression
Exploring the combined anti-cancer effects of sodium butyrate and celastrol in glioblastoma cell lines: a novel therapeutic approach
Bahar Kartal
Farika Nur Denizler-Ebiri
Mehmet Taşpınar
Original Paper Open access 26 March 2024 Article: 97
Bioinformatics-based screening and analysis of the key genes involved in the influence of antiangiogenesis on myeloid-derived suppressor cells and their effects on the immune microenvironment
XiangFei Zhao
RuGang Zhao
Yi Hu
Original Paper 25 March 2024 Article: 96
Physical characterization and bioavailability assessment of 5-fluorouracil-based nanostructured lipid carrier (NLC): In vitro drug release, Hemolysis, and permeability modulation
Mainuddin
Anoop Kumar
Amulya Jindal
Original Paper 25 March 2024 Article: 95
Regulation of cancer progression by CK2: an emerging therapeutic target
Shakeel Hussain
Yilei Guo
Yongzhong Hou
Review Article 25 March 2024 Article: 94
Investigation of cellular communication and signaling pathways in tumor microenvironment for high TP53-expressing osteosarcoma cells through single-cell RNA sequencing
Kai Xiong
Yuqi Fang
Bo Zhu
Original Paper 25 March 2024 Article: 93
Estrogen-receptor status determines differential regulation of α1- and α2-adrenoceptor-mediated cell survival, angiogenesis, and intracellular signaling responses in breast cancer cell lines
Hannah P. Priyanka
Uday P. Pratap
Srinivasan ThyagaRajan
Original Paper 25 March 2024 Article: 92
Part of 2 collections:

Immune checkpoint inhibitors in cancer treatment

Immune checkpoint inhibitors in cancer treatment
The efficacy and safety of PD-1 inhibitor combined with TACE in the first-line treatment of unresectable hepatocellular carcinoma
Qing-Qing Liu
Xiang-Xu Wang
Hong-Mei Zhang
Original Paper 25 March 2024 Article: 91
Part of 1 collection:

Immune checkpoint inhibitors in cancer treatment
Design and evaluation of a multiepitope vaccine for pancreatic cancer using immune-dominant epitopes derived from the signature proteome in expression datasets
Sooram Banesh
Nupoor Patil
Prakash Saudagar
Original Paper 24 March 2024 Article: 90

Volume 41, Issue 5

Challenges and strategies in relation to effective CAR-T cell immunotherapy for solid tumors

Anti-cancer potential of zerumbone in cancer and glioma: current trends and future perspectives

Ferroptosis is an effective strategy for cancer therapy

N-methyl-D-aspartate receptors and thymoquinone induce apoptosis and alteration in mitochondria in colorectal cancer cells

Comprehensive review of the repositioning of non-oncologic drugs for cancer immunotherapy

Correction to: Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression

FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner

The role of SWI/SNF complexes in digestive system neoplasms

Identification of small molecule inhibitors against Lin28/let-7 to suppress tumor progression and its alleviation role in LIN28-dependent glucose metabolism

Chlordiazepoxide against signalling, receptor and regulatory proteins of breast cancer: a structure-based in-silico approach

Liver cancer wars: plant-derived polyphenols strike back

Exploring the immunomodulatory potential of Brahmi (Bacopa monnieri) in the treatment of invasive ductal carcinoma

Dual function of activated PPARγ by ligands on tumor growth and immunotherapy

A novel α,β-unsaturated ketone inhibits leukemia cell growth as PARP1 inhibitor

Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies

Coadministration of doxorubicin with vitamin D3, Lactobacillus acidophilus, and Lactobacillus casei in the 4T1 mouse model of breast cancer: anticancer and enteroprotective effects

Combination of IFN-gamma with STING agonist and PD-1 immune checkpoint blockade: a potential immunotherapy for gastric cancer

Study of the effect of sFRP1 protein on molecules involved in the regulation of DNA methylation in CML cell line

Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: new insights

Immunomodulatory effects of Diospyros peregrina fruit preparation (DFP) in non-small cell lung cancer (NSCLC) by utilizing dendritic cell-mediated antigen presentation and T helper (TH) cell differentiation

Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment

Citalopram, an antipsychotic agent, induces G1/G0 phase cell cycle arrest and promotes apoptosis in human laryngeal carcinoma HEP-2 cells

Unlocking the potential: phenylboronic acid as a nuclear-targeting boron agent for neutron capture therapy

Regulation of hippo signaling mediated apoptosis by Rauvolfia tetraphylla in triple-negative breast cancer

Investigating the correlation between prominent viruses and hematological malignancies: a literature review

Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer

YWHAG promotes colorectal cancer progression by regulating the CTTN-Wnt/β-catenin signaling axis

Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer

Potential role of immune cell therapy in gynecological cancer and future promises: a comprehensive review

Exploring the combined anti-cancer effects of sodium butyrate and celastrol in glioblastoma cell lines: a novel therapeutic approach

Bioinformatics-based screening and analysis of the key genes involved in the influence of antiangiogenesis on myeloid-derived suppressor cells and their effects on the immune microenvironment

Physical characterization and bioavailability assessment of 5-fluorouracil-based nanostructured lipid carrier (NLC): In vitro drug release, Hemolysis, and permeability modulation

Regulation of cancer progression by CK2: an emerging therapeutic target

Investigation of cellular communication and signaling pathways in tumor microenvironment for high TP53-expressing osteosarcoma cells through single-cell RNA sequencing

Estrogen-receptor status determines differential regulation of α1- and α2-adrenoceptor-mediated cell survival, angiogenesis, and intracellular signaling responses in breast cancer cell lines

The efficacy and safety of PD-1 inhibitor combined with TACE in the first-line treatment of unresectable hepatocellular carcinoma

Design and evaluation of a multiepitope vaccine for pancreatic cancer using immune-dominant epitopes derived from the signature proteome in expression datasets

Navigation